3rd generation glp 1 agonist GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Lindsay Maggio, MD, MPH |

Metformin : This prescription medication has a long and well-researched history of not only managing insulin resistance and age-related weight gain, but reducing inflammation, improving symptoms of menopause (such as fatigue), and even promoting longevity

Despite the positive results, due to the limited number of included studies, further randomized controlled trials are needed to investigate the safety and efficacy of SGLT2i and GLP-1RAs as first-line treatment options for patients with T2DM at low cardiovascular disease risk, particularly when compared to metformin

Likewise, GLP-1RAs can lower postprandial glycemia predominantly by slowing gastric emptying and promoting weight loss [6, 7]

This isnt about forcing yourself to stop eating

This study did not include animal research, clinical trials, or the use of plants